Abstract
Genetic absence epilepsy rats from Strasbourg (GAERS), a selectively inbred strain of Wistar rats, has been validated as an experimental model for human absence epilepsy. In this model, systemic administration of ethosuximide (ETX) was shown to reduce the spike and wave discharges (SWD). In this study, gamma-aminobutyric acid (GABA) and L-glutamic acid levels in response to ETX injections (i.p., 100 mg/kg) were measured in the microdialysis samples collected from the ventrolateral thalamus (VLT) and the primary motor cortex (M1) area of Wistar rats and GAERS by using HPLC with fluorescent detection. Throughout the microdialysis procedure, continuous EEG recording was performed where ETX was shown to suppress the SWD activity. We demonstrated increased basal GABA levels in the M1 and VLT of GAERS, and ETX treatment did not produce any effect on higher GABA levels in the VLT, but suppressed the increased GABA levels significantly in the M1 of GAERS. All these findings denote the importance of corticothalamic circuitry and the role of increased GABA tonus in primary motor cortex and thalamus of GAERS. The primary motor cortex also seems to be involved in the SWD activity and ETX exerts, at least partially, its neurotransmitter eff...Continue Reading
References
Jan 1, 1992·Neuroscience·Z LiuC Marescaux
Jan 1, 1992·Journal of Neural Transmission. Supplementum·C MarescauxA Depaulis
Jan 1, 1992·Journal of Neural Transmission. Supplementum·G AvanziniM Vergnes
Apr 5, 1991·Brain Research·Z LiuC Marescaux
Feb 1, 1988·Trends in Neurosciences·P Gloor, R G Fariello
Jun 1, 1989·Annals of Neurology·D A CoulterD A Prince
Mar 13, 1989·Neuroscience Letters·D A CoulterD A Prince
Jul 1, 1986·Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society·A F MirskyM S Myslobodsky
Apr 1, 1987·Experimental Neurology·M VergnesJ M Warter
Dec 1, 1980·Journal of Neuroscience Methods·G PaxinosP C Emson
Jan 27, 1984·Neuroscience Letters·M VergnesJ M Warter
Apr 1, 1982·Experimental Neurology·M Avoli, P Gloor
Feb 1, 1995·Italian Journal of Neurological Sciences·C Marescaux, M Vergnes
Sep 7, 2000·Neuropharmacology·D A RichardsN G Bowery
Mar 22, 2001·Proceedings of the National Academy of Sciences of the United States of America·M Steriade
May 4, 2002·Nature Reviews. Neuroscience·Vincenzo Crunelli, Nathalie Leresche
Jul 3, 2003·Epilepsy Research·Douglas A RichardsVincenzo Crunelli
Oct 16, 2003·Trends in Pharmacological Sciences·Jon-Paul A ManningNorman G Bowery
Oct 17, 2003·British Journal of Cancer·B L ChangJ Xu
Dec 12, 2003·Neuroscience·J P A ManningN G Bowery
Aug 17, 2004·Epilepsy Currents·John R. Huguenard
Aug 17, 2004·Epilepsy Currents·Vincenzo Crunelli, Nathalie Leresche
Jul 26, 2005·Brain Research·Serap SirvanciTangul San
Citations
Jan 1, 2013·In Silico Pharmacology·Sarah FliegelHamid R Noori
Feb 22, 2012·Science Translational Medicine·Elizabeth TringhamTerrance P Snutch
Jul 31, 2012·Neuroscience Letters·L YatsenkoN Himmelreich
Sep 29, 2011·Neuropharmacology·Stuart D GreenhillRoland S G Jones
Dec 23, 2009·Brain Research Reviews·Marco WeiergräberRüdiger Köhling
Jul 14, 2007·CNS Drug Reviews·M Zafer Gören, Filiz Onat
Feb 14, 2008·Journal of Pharmacological Sciences·Hasan R YananliFiliz Y Onat
Apr 11, 2018·Epilepsia·Jeffrey R TenneyTracy A Glauser
Jun 6, 2013·ISRN Neurology·A S Bazyan, G van Luijtelaar
Oct 7, 2018·Brain Topography·Ailiang MiaoXiaoshan Wang
May 6, 2021·Journal of Neurophysiology·Sean TatumDaniel S Barth